Author

Nazli Bahrami

Akershus University Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Andliena TahiriiD· 1 shared Arvind Y.M. Sundaram· 1 shared Chandra L. TheesfeldiD· 1 shared Charles Joseph VaskeiD· 1 shared Denise G O'MahonyiD· 1 shared Grethe Grenaker Alnæs· 1 shared Ina Skaara BrorsoniD· 1 shared Jürgen GeisleriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andliena TahiriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CLONAL SELECTION SUPPORTED BY SINGLE CELL DNA SEQUENCING REVEALS HORMONAL ADAPTATION AND RESISTANCE IN LOCALLY ADVANCED BREAST CANCER DURING NEOADJUVANT AROMATASE INHIBITION

Denise G O'Mahony, Tom Lesluyes, Ina Skaara Brorson, Patrik Vernhoff, Ksenia Sokolova, Miriam R. R. Aure, Grethe Grenaker Alnæs, Rebecca Mae Hooen, Arvind Y.M. Sundaram, Chandra L. Theesfeld, Stephanie Beate Geisler, Torill Sauer, Nazli Bahrami, Rahul Parulkar, Andliena Tahiri, , Vessela Nedelcheva Kristensen

This study uses whole-exome sequencing and single-cell DNA sequencing to analyze subclonal evolution in breast cancer during aromatase inhibitor treatment, identifying resistance mechanisms and actionable targets.

bioRxiv · Sep 24, 2025 · PreprintCancer Biology